心房細動治療薬の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Atrial Fibrillation Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Product Profiles
04.1.1 Pradaxa/ Prazaxa
04.1.2 Xarelto
04.1.3 Multaq

05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology

06.Introduction

07.Disease Overview
07.1 Understanding the Disease
07.2 Classification
07.3 Pathophysiology
07.4 Causes
07.5 Epidemiology
07.6 Management
07.7 Economic Burden

08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis

09.Market Segmentation by Class of Drugs
09.1.1 Anticoagulants
09.1.2 Anti-arrythmics

10.Geographical Segmentation

11.Buying Criteria

12.Market Growth Drivers

13.Drivers and their Impact

14.Market Challenges

15.Impact of Drivers and Challenges

16.Market Trends

17.Trends and their Impact

18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 Boehringer Ingelheim
18.2.2 Sanofi
18.2.3 Janssen Pharmaceuticals
18.3 Other Prominent Vendors

19.Key Vendor Analysis
19.1 Boehringer Ingelheim
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2013
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Geographical Segmentation by Revenue 2013
19.1.6 Business Strategy
19.1.7 Recent Developments
19.1.8 SWOT Analysis
19.2 Janssen Pharmaceuticals
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Recent Developments
19.2.4 SWOT Analysis
19.3 Sanofi
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Business Segmentation
19.3.4 Revenue by Business Segmentation
19.3.5 Revenue Comparison 2012 and 2013
19.3.6 Sales by Geography
19.3.7 Business Strategy
19.3.8 Key Developments
19.3.9 SWOT Analysis

20.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Types of Atrial Fibrillation
Exhibit 3: Risk Factors Associated with Atrial Fibrillation
Exhibit 4: Management of Atrial Fibrillation
Exhibit 5: Economic Burden of Atrial Fibrillation
Exhibit 6: Global Atrial Fibrillation Market 2014-2019 (US$ million)
Exhibit 7: Challenges and Drivers of Global Atrial Fibrillation Market
Exhibit 8: Global Atrial Fibrillation Market Segmentation by Class of Drugs
Exhibit 9: Sub-classification of Anti-arrythmics
Exhibit 10: Segmentation of Global Atrial Fibrillation Market by Geography 2014
Exhibit 11: Buying Criteria of the Global Atrial Fibrillation market
Exhibit 12: World’s Population Aged 60 and Above (2010-2020)
Exhibit 13: The Global Prevalence of Atrial Fibrillation 2006-2016 (Million)
Exhibit 14: Drivers and their Impact on the Key Customer Category of the Global Atrial Fibrillation market
Exhibit 15: Drivers and their Impact on Geographies in Global Atrial Fibrillation Market
Exhibit 16: Global Atrial Fibrillation Market Share Analysis 2014
Exhibit 17: Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 18: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 19: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 20: Sanofi SA: Business Segmentation
Exhibit 21: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 22: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 23: Sanofi SA: Sales Revenue by Geographical Segmentation 2013


【レポート販売概要】

■ タイトル:心房細動治療薬の世界市場2015-2019
■ 英文:Global Atrial Fibrillation Market 2015-2019
■ 発行日:2015年1月28日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5053
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。